Haemonetics to Present at Raymond James 45th Annual Institutional Investors Conference

Author's Avatar
Feb 21, 2024

PR Newswire

BOSTON, Feb. 21, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Raymond James 45th Annual Institutional Investors Conference on Tuesday, March 5, 2024 at 7:30 a.m. ET.

Haemonetics_Corporation_Logo.jpg

The public may access a live webcast of the fireside chat at Haemonetics' Investor Relations website or at the following link: https://wsw.com/webcast/rj129/hae/1445840. A replay of the recorded webcast will become accessible 12 hours after the event and will be available for 90 days on Haemonetics' Investor Relations website.

About Haemonetics

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contacts:

Olga Guyette, Sr. Director-Investor Relations & Treasury

David Trenk, Manager-Investor Relations

(781) 356-9763

(203) 733-4987

[email protected]

[email protected]

Media Contact:

Josh Gitelson, Director-Global Communications

(781) 356-9776

[email protected]

favicon.png?sn=NE42631&sd=2024-02-21 View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-to-present-at-raymond-james-45th-annual-institutional-investors-conference-302068095.html

SOURCE Haemonetics Corporation

rt.gif?NewsItemId=NE42631&Transmission_Id=202402211757PR_NEWS_USPR_____NE42631&DateId=20240221